Literature DB >> 3377472

Stability constants of zinc complexes affect common cold treatment results.

G A Eby.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 3377472      PMCID： PMC172233          DOI： 10.1128/AAC.32.4.606

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  9 in total

1.  Ascorbic acid for the common cold. A prophylactic and therapeutic trial.

Authors:  T R Karlowski; T C Chalmers; L D Frenkel; A Z Kapikian; T L Lewis; J M Lynch
Journal:  JAMA       Date:  1975-03-10       Impact factor: 56.272

2.  In vitro activity of zinc salts against human rhinoviruses.

Authors:  F C Geist; J A Bateman; F G Hayden
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

3.  Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds.

Authors:  B M Farr; E M Conner; R F Betts; J Oleske; A Minnefor; J M Gwaltney
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

4.  A novel form of host defence: membrane protection by Ca2+ and Zn2+.

Authors:  C A Pasternak
Journal:  Biosci Rep       Date:  1987-02       Impact factor: 3.840

5.  The problems of taste in placebo matching: an evaluation of zinc gluconate for the common cold.

Authors:  B M Farr; J M Gwaltney
Journal:  J Chronic Dis       Date:  1987

6.  Failure of effervescent zinc acetate lozenges to alter the course of upper respiratory tract infections in Australian adults.

Authors:  R M Douglas; H B Miles; B W Moore; P Ryan; C B Pinnock
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

7.  Reduction in duration of common colds by zinc gluconate lozenges in a double-blind study.

Authors:  G A Eby; D R Davis; W W Halcomb
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

8.  Sites of rhinovirus recovery after point inoculation of the upper airway.

Authors:  B Winther; J M Gwaltney; N Mygind; R B Turner; J O Hendley
Journal:  JAMA       Date:  1986-10-03       Impact factor: 56.272

9.  Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges.

Authors:  W Al-Nakib; P G Higgins; I Barrow; G Batstone; D A Tyrrell
Journal:  J Antimicrob Chemother       Date:  1987-12       Impact factor: 5.790
  9 in total
  5 in total

Review 1.  Zinc gluconate and the common cold. Review of randomized controlled trials.

Authors:  S Marshall
Journal:  Can Fam Physician       Date:  1998-05       Impact factor: 3.275

2.  Zinc lozenges may shorten the duration of colds: a systematic review.

Authors:  Harri Hemilä
Journal:  Open Respir Med J       Date:  2011-06-23

3.  The effectiveness of high dose zinc acetate lozenges on various common cold symptoms: a meta-analysis.

Authors:  Harri Hemilä; Elizabeth Chalker
Journal:  BMC Fam Pract       Date:  2015-02-25       Impact factor: 2.497

Review 4.  Zinc lozenges reduce the duration of common cold symptoms.

Authors: 
Journal:  Nutr Rev       Date:  1997-03       Impact factor: 7.110

5.  Zinc lozenges and the common cold: a meta-analysis comparing zinc acetate and zinc gluconate, and the role of zinc dosage.

Authors:  Harri Hemilä
Journal:  JRSM Open       Date:  2017-05-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.